Symbols / IVF Stock $2.14 -1.38% INVO Fertility, Inc.

Healthcare • Medical Devices • United States • NCM
IVF (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Steven M. Shum
Exch · Country NCM · United States
Market Cap 3.46M
Enterprise Value 13.56M
Income -11.22M
Sales 6.94M
FCF (ttm) 950.67K
Book/sh -22.34
Cash/sh 0.94
Employees 33
Insider 10d
IPO Nov 02, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E -0.09
PEG
P/S 0.50
P/B -0.10
P/C
EV/EBITDA -1.91
EV/Sales 1.95
Quick Ratio 0.07
Current Ratio 0.12
Debt/Eq 72.39
LT Debt/Eq
EPS (ttm) -1,474.40
EPS next Y -23.20
EPS Growth
Revenue Growth 22.60%
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2025-04-30
Earnings (prior) 2025-04-30
ROA -48.36%
ROE
ROIC
Gross Margin 39.17%
Oper. Margin -93.08%
Profit Margin 0.00%
Shs Outstand 1.62M
Shs Float 349.69K
Insider Own 1.04%
Instit Own 16.46%
Short Float 5.92%
Short Ratio 1.50
Short Interest 95.66K
52W High 384.00
vs 52W High -99.44%
52W Low 1.92
vs 52W Low 11.46%
Beta
Impl. Vol.
Rel Volume 0.08
Avg Volume 319.02K
Volume 24.57K
Target (mean) $20.00
Tgt Median $20.00
Tgt Low $20.00
Tgt High $20.00
# Analysts 1
Recom None
Prev Close $2.17
Price $2.14
Change -1.38%
About

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.14
Low
$20.00
High
$20.00
Mean
$20.00
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-03 SZOT MATTHEW K Director 4 $1.52 $6
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
6.53
+116.25%
3.02
+267.38%
0.82
-80.24%
4.16
Operating Revenue
6.53
+116.25%
3.02
+267.38%
0.82
-80.24%
4.16
Cost Of Revenue
3.66
+89.09%
1.93
+127.37%
0.85
+486.53%
0.15
Reconciled Cost Of Revenue
3.66
+89.09%
1.93
+127.37%
0.85
+486.53%
0.15
Gross Profit
2.87
+164.63%
1.09
+3901.14%
-0.03
-100.71%
4.02
Operating Expense
10.49
+33.55%
7.85
-25.90%
10.60
+14.80%
9.23
Research And Development
0.49
+195.07%
0.17
-69.50%
0.54
+151.37%
0.22
Selling General And Administration
9.08
+21.27%
7.49
-24.96%
9.98
+10.66%
9.02
Total Expenses
14.15
+44.53%
9.79
-14.51%
11.45
+22.10%
9.38
Operating Income
-7.61
-12.51%
-6.77
+36.32%
-10.63
-103.71%
-5.22
Total Operating Income As Reported
-8.13
-20.07%
-6.77
+36.32%
-10.63
-103.71%
-5.22
EBITDA
-7.14
-3.82%
-6.88
+36.02%
-10.75
-106.04%
-5.22
Normalized EBITDA
-6.69
-0.89%
-6.63
+38.35%
-10.75
-100.01%
-5.37
Reconciled Depreciation
0.92
+357.76%
0.20
+159.89%
0.08
-53.46%
0.17
EBIT
-8.06
-13.86%
-7.08
+34.62%
-10.83
-101.12%
-5.38
Total Unusual Items
-0.46
-80.52%
-0.25
-7220.01%
-0.00
-102.23%
0.16
Total Unusual Items Excluding Goodwill
-0.46
-80.52%
-0.25
-7220.01%
-0.00
-102.23%
0.16
Special Income Charges
-0.46
-80.82%
-0.25
0.00
-100.00%
0.16
Other Special Charges
-0.05
-133.11%
0.16
-0.16
Write Off
0.00
-100.00%
0.09
0.00
Net Income
-9.10
-13.21%
-8.03
+26.24%
-10.89
-63.68%
-6.65
Pretax Income
-9.12
-13.89%
-8.01
+26.47%
-10.89
-63.75%
-6.65
Net Non Operating Interest Income Expense
-1.06
-14.09%
-0.93
-1465.70%
-0.06
+95.31%
-1.26
Interest Expense Non Operating
1.06
+14.09%
0.93
+1457.59%
0.06
-95.30%
1.27
Net Interest Income
-1.06
-14.09%
-0.93
-1465.70%
-0.06
+95.31%
-1.26
Interest Expense
1.06
+14.09%
0.93
+1457.59%
0.06
-95.30%
1.27
Interest Income Non Operating
0.00
-100.00%
0.00
-91.58%
0.00
Interest Income
0.00
-100.00%
0.00
-91.58%
0.00
Other Income Expense
-0.45
-42.96%
-0.31
-53.79%
-0.20
-18.65%
-0.17
Gain On Sale Of Security
-0.00
+87.87%
-0.00
+2.01%
-0.00
Tax Provision
-0.02
-182.46%
0.03
+867.48%
0.00
-39.71%
0.00
Tax Rate For Calcs
0.00
-98.81%
0.00
+0.00%
0.00
-22.22%
0.00
Tax Effect Of Unusual Items
-0.00
+97.85%
-0.05
-7220.01%
-0.00
-101.73%
0.04
Net Income Including Noncontrolling Interests
-9.10
-13.21%
-8.03
+26.24%
-10.89
-63.68%
-6.65
Net Income From Continuing Operation Net Minority Interest
-9.10
-13.21%
-8.03
+26.24%
-10.89
-63.68%
-6.65
Net Income From Continuing And Discontinued Operation
-9.10
-13.21%
-8.03
+26.24%
-10.89
-63.68%
-6.65
Net Income Continuous Operations
-9.10
-13.21%
-8.03
+26.24%
-10.89
-63.68%
-6.65
Normalized Income
-8.64
-10.28%
-7.83
+28.06%
-10.89
-60.89%
-6.77
Net Income Common Stockholders
-9.35
-16.33%
-8.03
+26.24%
-10.89
-63.68%
-6.65
Otherunder Preferred Stock Dividend
0.25
0.00
Diluted EPS
-3,622.80
+21.99%
-4,644.28
+82.01%
-25,811.64
-60.57%
-16,074.73
Basic EPS
-3,622.80
+21.99%
-4,644.28
+82.01%
-25,811.64
-60.57%
-16,074.73
Basic Average Shares
0.00
+49.08%
0.00
+309.95%
0.00
+1.93%
0.00
Diluted Average Shares
0.00
+49.08%
0.00
+309.95%
0.00
+1.93%
0.00
Diluted NI Availto Com Stockholders
-9.35
-16.33%
-8.03
+26.24%
-10.89
-63.68%
-6.65
Depreciation Amortization Depletion Income Statement
0.92
+357.76%
0.20
+159.89%
0.08
Depreciation And Amortization In Income Statement
0.92
+357.76%
0.20
+159.89%
0.08
Earnings From Equity Interest
0.01
+115.01%
-0.06
+69.95%
-0.20
+38.77%
-0.33
Gain On Sale Of PPE
-0.51
0.00
Line Item Trend 2023-12-31
Total Assets
18.51
Current Assets
1.26
Cash Cash Equivalents And Short Term Investments
0.23
Cash And Cash Equivalents
0.23
Cash Financial
0.23
Receivables
0.14
Accounts Receivable
0.14
Inventory
0.26
Raw Materials
0.05
Work In Process
Finished Goods
0.21
Prepaid Assets
Other Current Assets
0.62
Total Non Current Assets
17.25
Net PPE
4.19
Gross PPE
4.42
Accumulated Depreciation
-0.23
Properties
0.00
Machinery Furniture Equipment
0.09
Other Properties
3.80
Leases
0.54
Goodwill And Other Intangible Assets
9.97
Goodwill
5.88
Other Intangible Assets
4.09
Investments And Advances
3.09
Long Term Equity Investment
3.09
Total Liabilities Net Minority Interest
17.61
Current Liabilities
8.00
Payables And Accrued Expenses
4.83
Payables
4.83
Accounts Payable
2.33
Other Payable
2.50
Pensionand Other Post Retirement Benefit Plans Current
0.72
Total Tax Payable
Income Tax Payable
Current Debt And Capital Lease Obligation
1.69
Current Debt
1.51
Other Current Borrowings
0.63
Current Capital Lease Obligation
0.18
Current Deferred Liabilities
0.41
Current Deferred Revenue
0.41
Other Current Liabilities
0.35
Total Non Current Liabilities Net Minority Interest
9.61
Long Term Debt And Capital Lease Obligation
4.61
Long Term Debt
1.25
Long Term Capital Lease Obligation
3.36
Tradeand Other Payables Non Current
5.00
Non Current Deferred Liabilities
0.00
Non Current Deferred Revenue
Non Current Deferred Taxes Liabilities
0.00
Other Non Current Liabilities
0.00
Preferred Securities Outside Stock Equity
0.00
Stockholders Equity
0.89
Common Stock Equity
-5.11
Capital Stock
6.00
Common Stock
0.00
Preferred Stock
6.00
Share Issued
0.00
Ordinary Shares Number
0.00
Treasury Shares Number
0.00
Additional Paid In Capital
52.71
Retained Earnings
-57.82
Total Equity Gross Minority Interest
0.89
Total Capitalization
2.15
Working Capital
-6.74
Invested Capital
-2.34
Total Debt
6.30
Net Debt
2.53
Capital Lease Obligations
3.54
Net Tangible Assets
-9.08
Tangible Book Value
-15.08
Current Notes Payable
0.88
Investmentsin Joint Venturesat Cost
0.92
Investmentsin Subsidiariesat Cost
2.17
Preferred Stock Equity
6.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-2.97
+37.45%
-4.76
+27.99%
-6.60
-9.51%
-6.03
Cash Flow From Continuing Operating Activities
-2.97
+37.45%
-4.76
+27.99%
-6.60
-9.51%
-6.03
Net Income From Continuing Operations
-9.10
-13.21%
-8.03
+26.24%
-10.89
-63.68%
-6.65
Depreciation Amortization Depletion
0.92
+357.76%
0.20
+159.89%
0.08
-53.46%
0.17
Depreciation
0.31
+84.44%
0.17
Depreciation And Amortization
0.92
+357.76%
0.20
+159.89%
0.08
-53.46%
0.17
Other Non Cash Items
1.21
+34.02%
0.90
+421.38%
0.17
-85.47%
1.19
Stock Based Compensation
1.59
+14.08%
1.39
-37.35%
2.22
-17.86%
2.71
Asset Impairment Charge
0.00
-100.00%
0.09
-32.09%
0.13
0.00
Operating Gains Losses
0.54
+142.95%
0.22
+11.46%
0.20
+19.08%
0.17
Gain Loss On Sale Of PPE
0.51
0.00
Change In Working Capital
1.86
+294.90%
0.47
-68.17%
1.48
+141.10%
-3.61
Change In Receivables
-0.03
+45.85%
-0.06
-137.64%
-0.03
+7.27%
-0.03
Changes In Account Receivables
-0.03
+45.85%
-0.06
-137.64%
-0.03
+7.27%
-0.03
Change In Inventory
0.04
+5043.98%
-0.00
-103.74%
0.02
+207.90%
-0.02
Change In Prepaid Assets
-0.16
+62.10%
-0.43
-566.88%
0.09
+174.15%
-0.12
Change In Payables And Accrued Expense
1.79
+117.88%
0.82
-35.24%
1.27
+840.71%
0.14
Change In Accrued Expense
0.44
+532.16%
-0.10
-127.90%
0.37
+1650.05%
0.02
Change In Payable
1.35
+46.07%
0.92
+2.28%
0.90
+692.32%
0.11
Change In Account Payable
1.35
+46.07%
0.92
+2.28%
0.90
+689.61%
0.11
Change In Other Working Capital
0.19
-32.53%
0.29
+149.98%
0.11
+103.27%
-3.51
Change In Other Current Assets
0.00
0.00
Change In Other Current Liabilities
0.03
+118.30%
-0.14
-2112.20%
0.01
+113.05%
-0.05
Investing Cash Flow
0.36
+114.59%
-2.49
-2971.87%
-0.08
+96.23%
-2.15
Cash Flow From Continuing Investing Activities
0.36
+114.59%
-2.49
-2971.87%
-0.08
+96.23%
-2.15
Net PPE Purchase And Sale
-0.11
+75.69%
-0.44
-4023.52%
-0.01
+97.41%
-0.42
Purchase Of PPE
-0.18
+58.69%
-0.44
-4023.52%
-0.01
+97.41%
-0.42
Sale Of PPE
0.08
0.00
Capital Expenditure
-0.18
+58.69%
-0.44
-3394.04%
-0.01
+97.20%
-0.45
Net Business Purchase And Sale
0.47
+123.02%
-2.05
-2893.41%
-0.07
+95.97%
-1.70
Purchase Of Business
0.00
+100.00%
-2.05
-2893.41%
-0.07
+95.97%
-1.70
Net Intangibles Purchase And Sale
0.00
+100.00%
-0.00
+95.01%
-0.04
Purchase Of Intangibles
0.00
+100.00%
-0.00
+95.01%
-0.04
Financing Cash Flow
3.12
-57.80%
7.39
+578.31%
1.09
-71.10%
3.77
Cash Flow From Continuing Financing Activities
3.12
-57.80%
7.39
+578.31%
1.09
-71.10%
3.77
Net Issuance Payments Of Debt
0.41
-75.38%
1.66
+108.11%
0.80
+420.00%
-0.25
Issuance Of Debt
1.34
-57.46%
3.16
+295.03%
0.80
0.00
Repayment Of Debt
-0.93
+37.51%
-1.50
0.00
+100.00%
-0.25
Long Term Debt Issuance
1.34
-57.46%
3.16
+295.03%
0.80
0.00
Long Term Debt Payments
-0.93
+37.51%
-1.50
0.00
+100.00%
-0.25
Net Long Term Debt Issuance
0.41
-75.38%
1.66
+108.11%
0.80
+420.00%
-0.25
Short Term Debt Issuance
0.00
-100.00%
0.10
-87.50%
0.80
0.00
Short Term Debt Payments
0.00
+100.00%
-0.25
Net Short Term Debt Issuance
0.00
-100.00%
0.10
-87.50%
0.80
+420.00%
-0.25
Net Common Stock Issuance
0.17
-97.10%
5.70
+1867.55%
0.29
-92.06%
3.65
Proceeds From Stock Option Exercised
0.90
+3442.09%
0.03
0.00
-100.00%
0.37
Changes In Cash
0.51
+257.70%
0.14
+102.54%
-5.59
-26.78%
-4.41
Beginning Cash Position
0.23
+157.86%
0.09
-98.41%
5.68
-43.70%
10.10
End Cash Position
0.74
+218.98%
0.23
+157.86%
0.09
-98.41%
5.68
Free Cash Flow
-3.16
+39.26%
-5.20
+21.41%
-6.62
-2.03%
-6.48
Interest Paid Supplemental Data
0.21
+2127.61%
0.01
0.00
-100.00%
0.05
Income Tax Paid Supplemental Data
0.00
0.00
-100.00%
0.00
-75.81%
0.00
Change In Income Tax Payable
0.00
+100.00%
-0.00
Change In Interest Payable
0.17
+36.85%
0.12
+7731.88%
0.00
-92.56%
0.02
Change In Tax Payable
0.00
+100.00%
-0.00
Common Stock Issuance
0.17
-97.10%
5.70
+1867.55%
0.29
-92.06%
3.65
Earnings Losses From Equity Investments
-0.01
-115.01%
0.06
-69.95%
0.20
-38.77%
0.33
Issuance Of Capital Stock
1.81
-68.27%
5.70
+1867.55%
0.29
-92.06%
3.65
Net Preferred Stock Issuance
1.64
0.00
Preferred Stock Issuance
1.64
0.00
Sale Of Business
0.47
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category